Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Deerfield Management Company, a healthcare investment firm, and Empire Discovery Institute (EDI) have established a research partnership to accelerate the translation of scientific discoveries into new therapies. Through a newly launched company, Empire-Deerfield Discovery & Development (ED3 ), Deerfield expects to invest up to $65 million over the next five years. EDI is
Are you working on a ClimateTech innovation? Venture For ClimateTech can help you validate your idea and potentially launch a viable business. Venture For ClimateTech is a non-profit global venture studio + accelerator program. They source the most promising ClimateTech innovators from around the world and offer them hands-on support
Join NextCorps for Startup Week – 5 days packed with free workshops and presentations, panel discussions, partner events, and networking opportunities. Register for one, some, or all sessions. This week is perfect for founders or people contemplating starting a business. See the full listing of events and register here.
Registration is now open for the for the Ain Center for Entrepreneurship’s Buzz Lab Boot Camp, a free virtual workshop series for entrepreneurs, small business owners and aspiring innovators in the greater Rochester region. Featuring instructors from the Simon Business School and local entrepreneurs and business leaders, the series runs on
R2i is a multi-stakeholder initiative to Connect organizations, investors, and individuals within our community to Israeli Companies to improve our quality of life. It will connect Israeli startups that want to expand into the US market with local entities to establish Business Partnerships and increase activity and collaboration. Initiated by
Oscine Corporation is a biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC). SEATTLE, Oct. 30, 2020 /PRNewswire/ — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today the acquisition of Oscine Corp., a company developing potentially curative or disease